Apollo Hospitals’ Suneeta Reddy to sell stake worth ₹1,395 crore

A member of the General Manager of Apollo Hospitals Enterprises Ltd (AHEL), Suneeta Redy and a member of the Promoter family, will evacuate the company’s partial share of the company through one or more agreements on Friday, August 22.

The second of the four daughters of AHEL Founder Prathap C. Reddy sells 1.8 million shares in the company, which is equal to 1.25% stock shares. Mint.

The process is valuable La1,395 crore, with floor price La7.747 per share. This is a 2.26% discount on Thursday’s close price La7.926 in NSE. Morgan Stanley India is the only Bocunner of the agreement.

Change in Sharing

Redy currently has 3.36% shares and has 4.83 million shares. After the sale, Holding would drop to 2.11%.

AHEL’s market value LaOn Thursday, 1.14 trillion in NSE on the market.

Read more: Apollo Hospitals’ clinical sensitivity affects investors. However, expansion creates a test.

AHEL did not answer Mint Queries about sales during publishing.

Apollo Hospitals, one of the largest hospital chains in the country, start an ambitious expansion plan while competing to go beyond the nuclear markets of private hospital chains across the country.

All competitors such as Max Healthcare, Narana and Aster DM announced their large -scale expansion plans for the next four to five years.

Apollo plans to add 4,300 beds in the next five years and La7,600 crore. The company said the first stage of adding 2,000 beds continues.

The hospital chain is trying to operate six new hospitals by adding more than 1,500 new beds this year. Mint In a previous conversation.

In the first quarter of the FY26, Apollo Hospitals, multi-channel pharmacy and digital health business, a new asset to be listed in the next 12-18 months, Apollo Healthtech’e, to unlock the value for the shareholders announced.

Read more: Apollo Hospitals Eyes Medical Tourism Increase, Capacity Growth in FY26

In the second quarter, the company reported a 15% increase in income from operations. La5.842 CRORE, INTEREST, TAX, DISCLAIMER AND PREVENTION PRE -BASING EARNING (EBITDA) increased by 26% La852 Crore. Net profit grew by 42% annually La433 CRORE, La305 Crore a year ago.

Growth, health services, retail health and diagnoses, digital health and multi -channel pharmacy, including three businesses.